期刊文献+

氨磺必利与氯氮平治疗难治性精神分裂症随机开放对照研究 被引量:3

下载PDF
导出
摘要 目的:比较氨磺必利与氯氮平治疗难治性精神分裂症的疗效和安全性。方法:选择68例难治性精神分裂症患者随机分为氨磺必利组和氯氮平组各34例,于治疗前和治疗后8周末评定PANSS量表,评估不良反应发生率。结果:氨磺必利组总有效率为55.88%,氯氮平组总有效率为58.82%,两组总疗效无显著差异(P>0.05);氨磺必利组PANSS阴性症状量表减分率明显大于氯氮平组(P=0.022,P<0.05)。不良反应发生率氨磺必利组明显低于氯氮平组(2=3.56,P<0.05)。结论:氨磺必利疗效肯定,不良反应少,对阴性症状的疗效更好。
作者 田海佳
机构地区 温州康宁医院
出处 《中国高等医学教育》 2014年第9期138-139,共2页 China Higher Medical Education
  • 相关文献

参考文献2

二级参考文献24

  • 1甘景梨,胡兴焕,高存友,李晓琼,毋江,陈建辉,史建军,杨春.立体定向毁损术治疗难治性精神分裂症的随访研究[J].中国行为医学科学,2005,14(10):914-916. 被引量:2
  • 2王连仲,尹忠民,江晓莲,闻华,王磊,陈实,王金刚,李连祥.立体定向同期多靶点手术治疗难治性精神分裂症392例[J].中华神经外科杂志,2005,21(10):625-629. 被引量:29
  • 3Van Sant SP,Buckley PF. Pharmacotherapy for treatment-refractory schizophrenia[J].Expert Opinion on Pharmacotherapy,2011,(03):411-434.
  • 4Quintero J,Barbudo del Cura E,Lopez-Ibor MI. The evolving concept of treatment-resistant schizophrenia[J].Actas Espa olas de Psiquiatría:ACEPSI,2011,(04):236-250.
  • 5El-Badri S,Mellsop G. Clozapine use and outcomes among patients with treatment resistant schizophrenia[J].Australas Psychiatry,2011,(05):410-414.
  • 6Lindenmayer JP,Citrome L,Khan A. A randomized,double-blind,parallel-group,fixed-dose,clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment-resistant schizophrenia or schizoaffective disorder[J].Journal of Clinical Psychopharmacology,2011,(02):160-168.
  • 7Boggs DL,Nelson MW,Yu Y. Quetiapine at high doses for the treatment of refractory schizophrenia[J].Schizophrenia Research,2008.347-348.
  • 8De Risio A,Pancheri A,Simonetti G. Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia[J].Progress in Neuro-Psychopharmacology & Biological Psychiatry,2011,(04):1112-1116.
  • 9Barbui C,Accordini S,Nosè M. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care:a randomized,controlled trial[J].Journal of Clinical Psychopharmacology,2011,(03):266-273.
  • 10Kane JM,Correll CU,Goff DC. A multicenter,randomized,double-blind,placebo-controlled,16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherap[J].Journal of Clinical Psychiatry,2009,(10):1348-1357.

共引文献38

同被引文献15

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部